XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Equities

600721

CNE000000KQ1

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
5.81 ^CNY	-3.81%		-3.81%	-24.94%

04-25	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Xinjiang Baihuacun Co., Ltd. Provides Earnings Guidance for the Year 2016

January 24, 2017

Xinjiang Baihuacun Co., Ltd. provided earnings guidance for the year 2016. The company predicts the net profit belonging to shareholders of the listed company in 2016 to be between RMB 122 million and RMB 142 million.

Latest news about Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-25	CI
Nanjing Huanglong Biotechnology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd	04-23	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	10/10/23	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	11/04/23	CI
Bai Hua Cun Pharma Tech Unit Raises Capital by 90 Million Yuan	26/12/22	MT
Nanjing Huanglong Biotechnology Co., Ltd. announced that it expects to receive CNY 90 million in funding from Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd	22/12/22	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	23/08/22	CI
Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange Composite Index	13/06/22	CI
Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange A Share Index	13/06/22	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	29/03/22	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI
Jiangsu Leeway Biological Technology Co., Ltd. announced that it expects to receive CNY 45 million in funding from Xinjiang Baihuacun Co., Ltd.	16/09/21	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	17/08/21	CI
Xinjiang Baihuacun Co., Ltd. announced that it expects to receive CNY 338.746321 million in funding from Xinjiang Hualing International Medical Industry Development Co., Ltd	27/05/21	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21/04/21	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	30/03/21	CI
Xinjiang Baihuacun Co., Ltd. cancelled the transaction announced on June 8, 2020	04/03/21	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	22/10/20	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	19/08/20	CI
Xinjiang Baihuacun Co., Ltd. Provides Earnings Guidance for the First Half of 2020	19/07/20	CI
Xinjiang Baihuacun Co., Ltd. announced that it expects to receive CNY 429.904 million in funding from Xinjiang Hualing International Medical Industry Development Co., Ltd	07/06/20	CI

Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Duration

Period

Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

More charts

Company Profile

Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a China-based company principally engaged in pharmaceutical services. The Company's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The Company is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The Company is also engaged in leasing and property services. The Company mainly conducts business within the domestic market.

Sector

Biotechnology & Medical Research

Calendar

11/06/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD	-24.94%	319M
VERTEX PHARMACEUTICALS INCORPORATED	+10.79%	115B
REGENERON PHARMACEUTICALS, INC.	+11.65%	106B
BIONTECH SE	-6.20%	24.69B
ARGENX SE	-2.33%	21.97B
GENMAB A/S	-6.03%	19.27B
BEIGENE, LTD.	-13.41%	17.56B
WUXI APPTEC CO., LTD.	-40.50%	17.32B
NEUROCRINE BIOSCIENCES, INC.	+6.64%	14.03B
SAREPTA THERAPEUTICS, INC.	+31.84%	12.13B

Bio Therapeutic Drugs